Xcout Intel
DNA Nanobots competitors & alternatives
The 12 closest competitors and alternatives to DNA Nanobots among biotechnology companies — ranked by similarity to what DNA Nanobots actually does, not by market-cap band.
Subscribe to see DNA Nanobots’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About DNA Nanobots
DNA Nanobots, LLC is a biotechnology company founded in Columbus, Ohio, that develops products for targeted therapeutics and functionalized gene delivery.
DNA Nanobots at a glance
DNA Nanobots is a biotechnology company headquartered in United States. Its most recent funding round, Seed, raised $3.5M in December 2025. Xcout tracks 3 named people at DNA Nanobots, including James Lynch (CEO).
DNA Nanobots leadership
- James LynchCEO
- Patrick HalleyCTO Co-Founder
- Chris LucasCSO Co-Founder
DNA Nanobots funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 DNA Nanobots competitors
Ranked by semantic similarity — how close each company is to DNA Nanobots by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Healthcare & Life Sciences
ViaNautis Bio Ltd. is a groundbreaking nanomedicine company headquartered in Cambridge, UK, at the forefront of genetic therapies. The company leverages its proprietary polyNaut platform to develop novel products for delivering genetic medicines.
Life Science
Synthorx, Inc., founded in 2014, is a biotechnology company headquartered in La Jolla, California, that engineered expanded genetic alphabet technologies to discover and develop novel protein therapeutics.
Biotech
NanoVation Therapeutics is a platform developer headquartered in Vancouver, British Columbia, that partners with leading pharmaceutical and biotech companies to enable genetic medicines.
Similar biotechnology company
Myosana Therapeutics, Inc. is a biotechnology research company based in Seattle, Washington, pioneering non-viral gene therapy treatments for muscle diseases.
Biotech
Tessera Therapeutics is a biotechnology company developing programmable genetic medicines using its Gene Writing technology, which is based on mobile genetic elements to insert, replace, or modify DNA in cells. It aims to develop treatments for genetic diseases and other serious conditions, serving patients who need durable genetic therapies.
Similar biotechnology company
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Biotech
Hummingbird Bioscience is a precision biotherapeutics company located in Singapore. It focuses on discovering and developing engineered precision biotherapeutics to define the future of precision medicine.
Similar biotechnology company
Arbor Biotechnologies, Inc. is a next-generation gene editing company focused on discovering and developing precise genetic medicines for rare and complex diseases.
Biotech
Rejuvenate Bio, Inc. is a biotechnology company founded in 2019 and headquartered in San Diego, United States, specializing in innovative gene therapy applications.
Biotech
Genevant Sciences is a biotechnology company headquartered in Vancouver, British Columbia, that develops world-class delivery platforms including lipid nanoparticles.
Similar biotechnology company
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.
Similar biotechnology company
Mammoth Biosciences is a biotechnology company based in Brisbane, California developing diagnostic tests using CRISPR-Cas12a and CRISPR-based therapies using its proprietary ultra-small CRISPR systems. Several CRISPR-Cas systems identified through the company's metagenomics-based protein discovery platform, including members of the Casφ and Cas14 families of CRISPR-associated enzymes, have demonstrated potential for therapeutic genome editing in in vivo settings.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of DNA Nanobots and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for DNA Nanobotsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →